Tumor‐Adhesive Chitosan‐Derived Multi‐Immune Agonist Unleashes Strong and Durable Anti‐Cancer Immunity

Tumor‐Adhesive Chitosan‐Derived Multi‐Immune Agonist Unleashes Strong and Durable Anti‐Cancer Immunity

Abstract The immunomodulation of the tumor microenvironment is critical for effective cancer immunotherapy, particularly for tumors that exhibit limited responses to conventional treatments. However, current immune agonists developed for tumor immunomodulation face several challenges, such as poor i...

Full description

Saved in:
Bibliographic Details
Main Authors: Huilan He, Liang Liu, Yun Zheng, Jinlong Ji, Li Cao, Chunlian Ye, Yu Sun, Ying Zhang, Zhiyuan Zhong
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:Advanced Science
Subjects:
cancer therapy
immune agonist
immunomodulation
multi‐targets
radiotherapy
Online Access:https://doi.org/10.1002/advs.202414110
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items